• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
Anticholinergics

(cholinergic antagonists)

Sympathetic response
Atropine
Trihexyphenidyl (Artane)
Ipratropium bromide (Atrovent) Oxybutynin (Ditropan)
Trospium chloride (Sanctura)
Solifenacin (Vesicare)
Atropine
Class: Anticholinergic

Indication:
1. Induces mydriasis (pupil dilation) → topical
2. Inhibits bradycardia caused by excessive vagal activity
3. Reduces salivation and mucus production
4. Reverses effects of cholinergic agonists (i.e. mushroom poisoning)
5. Decreases cholinergic stimulation in Parkinson’s

MOA: Direct Mucarinic > nicotinic

AE:Constipation, urinary retention, blurred vision from dilated pupils, heat stroke (body temp regulators ineffective), decreased sweating, tachycardia
Trihexyphenidyl (Artane)
Class: Anticholinergic

Indication:
1. Used to treat Parkinson’s symptoms (i.e. decreases locomotor symptoms)
2. Restores “balance” between DA and Ach in neural circuits in basal ganglia

MOA: Direct mucarinic, nicotinic

AE:Constipation, urinary retention, blurred vision from dilated pupils, heat stroke (body temp regulators ineffective), decreased sweating, tachycardia
Ipratropium bromide (Atrovent)
Class: Anticholinergic

Indication: Bronchodilation in COPD, emphysema, and bronchitis

MOA: Direct muscarinic
Poor absorption

AE: Constipation, urinary retention, blurred vision from dilated pupils, heat stroke (body temp regulators ineffective), decreased sweating, tachycardia
Oxybutynin (Ditropan)
Trospium chloride (Sanctura) Solifenaci (Vesicare)
Class: Anticholinergic

Indication: Increases GI and urinary tract activity (smooth muscle contractions)

MOA: Direct Muscarinic (bladder)

AE:Constipation, urinary retention, blurred vision from dilated pupils, heat stroke (body temp regulators ineffective), decreased sweating, tachycardia
Anticholinergic adverse effects
Constipation, urinary retention, blurred vision from dilated pupils, heat stroke (body temp regulators ineffective), decreased sweating, tachycardia
Adrenergics
[Sympathomimetics]
(adrenergic agonists)
Epinephrine (Adrenalin)
Norepinephrine (Levophed)
Dopamine (Intropin)
Phenylephrine (Neo-Synephrine)
Dobutamine (Dobutrex)
Epinephrine (Adrenalin)
Class: Andrenergic

Indication: Increases BP and CO Reverses bronchospasm in anaphylactic shock

MOA: Direct, endogenous α, β1 (heart), β2 (lungs) Target tissues: heart, vascular and bronchial smooth muscle

AE: Headache, insomnia, paradoxical bronchospasm, tachycardia, N/V, hyperglycemia, HTN
Norepinephrine (Levophed)
Class: Andrenergic

Indication: Increases BP and CO by vasoconstriction (α1), β1- minor myocardial stimulation

MOA: Direct, endogenous Prefers α1, minimal β2

AE: Tremor, dizziness, dyspnea, bradycardia, HTN, renal failure
Dopamine (Intropin)
Class: Andrenergics

Indication: Increases cardiac output, BP, and improves renal blood flow

MOA: Direct, endogenous
D1- low dose
β1- 2-10 ug/kg/min
α1- >10 ug/kg/min

AE: Headache, dyspnea, arrhythmia, hypotension, vasoconstriction palpitations, angina, ECG change, N/V
Phenylephrine (Neo-Synephrine)
Class: Andrenergics

Indication: Systemic vasoconstriction → relieves decongestion

MOA: Direct α1

AE: Anxiety, headache, insomnia, arrhythmia, dyspnea, tremor, HTN, pallor, chest pain
Dobutamine (Dobutrex)
Class: Andrenergics

Indication: Increases heart contractibility (increased CO without increased HR)

MOA: Direct β1 (minimal α1)

AE: HTN, increased HR, premature ventricular contractions
Dopamine (Intropin)
Class: Andrenergics

Indication: Increases cardiac output, BP, and improves renal blood flow

MOA: Direct, endogenous
D1- low dose
β1- 2-10 ug/kg/min
α1- >10 ug/kg/min

AE: Headache, dyspnea, arrhythmia, hypotension, vasoconstriction palpitations, angina, ECG change, N/V
Phenylephrine (Neo-Synephrine)
Class: Andrenergics

Indication: Systemic vasoconstriction → relieves decongestion

MOA: Direct α1

AE: Anxiety, headache, insomnia, arrhythmia, dyspnea, tremor, HTN, pallor, chest pain
Dobutamine (Dobutrex)
Class: Andrenergics

Indication: Increases heart contractibility (increased CO without increased HR)

MOA: Direct β1 (minimal α1)

AE: HTN, increased HR, premature ventricular contractions